COVID-19 Treatments

• Canadian researchers discover ‘weak spot’ in COVID-19 virus key to treatments

  Researchers at the University of British Columbia have discovered what they are calling a `` weak spot'' in the virus that causes COVID-19.

  Health

  Aug 18, 2022
  
• White House presses Congress to approve ‘urgent’ COVID-19 funding

  The congressional stalemate over coronavirus funding has forced the federal government to curtail free treatment for the uninsured and to ration monoclonal antibody supplies.

  World

  Apr 25, 2022
  
• Advertisement
• Reality check: What is ‘flurona’ and can you tell if you have it?

  The term is used to describe a co-infection when a person catches the influenza virus and the coronavirus simultaneously.

  Health

  Jan 11, 2022
• Advertisement
• Sotrovimab COVID-19 drug: A look at how it’s being used to combat Omicron in Canada

  Sotrovimab is the only monoclonal antibody treatment that appears to be effective against the Omicron variant, according to medical experts.

  Health

  Jan 2, 2022
• Merck to make its COVID-19 antiviral pill in Canada, company announces

  Merck has reached an agreement with an Ontario pharmaceutical company to make its oral COVID-19 treatment, molnupiravir, in Canada, officials said Monday.

  Health

  Dec 6, 2021
• Pfizer files for U.S. authorization of its pill to treat COVID-19

  Pfizer says that its COVID-19 treatment pill can help to significantly cut the risk of death or hospitalization in high-risk adults.

  Health

  Nov 16, 2021
• Alberta rolling out new COVID-19 treatment in phases; Hinshaw warns it’s no substitute for vaccines

  Alberta is starting to administer a new treatment for some COVID-19 patients, the province's chief medical officer of health said Tuesday.

  Health

  Nov 10, 2021
• U.K. approves Merck antiviral pill to treat COVID-19

  The U.K. is the first country to approve Merck's molnupiravir antiviral treatment for COVID-19.

  Health

  Nov 4, 2021
• Advertisement
• Health Canada to review AstraZeneca’s COVID-19 prevention drug

  AstraZeneca has submitted its COVID-19 prevention drug to Health Canada for approval, which would make it the first antibody protection of its kind in Canada.

  Health

  Nov 3, 2021
• Advertisement
• AstraZeneca COVID-19 drug prevents severe disease if given early, company says

  The risk reduction was even better in patients who started therapy within just five days of initial symptoms, said company AstraZeneca.

  Health

  Oct 11, 2021